Difficulty: Medium
Average Score: 65%
Practice
A 52-year-old woman with end-stage multiple sclerosis who is currently taking several medications including prednisone and neostigmine is seen by a new physician. After examination, the patient has begun on dalfampridine. What is the most likely mechanism of action for this medication?
Correct answer
D
Rationale
Dalfampridine is a potassium channel blocker that improves nerve conduction in patients with multiple sclerosis by blocking potassium channels, which enhances action potential propagation.